ClinicalTrials.Veeva

Menu

Incidence and Spectrum of Acute Kidney Injury in Cirrhotics and Assessment of New Biomarkers as Early Predictors of Acute Kidney Injury

I

Institute of Liver and Biliary Sciences, India

Status

Completed

Conditions

Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT02016053
ILBS-AKI-02

Details and patient eligibility

About

500 patients with normal renal function will be prospectively studied and incidence, spectrum and natural history of AKI (Acute Kidney Injury) will be observed in them and in 200 patients with abnormal renal function fulfilling AKI (Acute Kidney Injury) criteria will be prospectively studied for 1 year. Also biomarkers will be studied and validated as early predictors of AKI (Acute Kidney Injury).

Enrollment

450 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Group A: 500 patients of cirrhosis with normal baseline renal function will be enrolled Group B : 200 patients who present with AKI (Acute Kidney Injury) will be enrolled

Exclusion criteria

  • Age < 18 or > 70 years
  • Preexisting Chronic Renal Disease
  • Patients with obstructive uropathy.
  • Cirrhosis with HCC (HepatoCellular Carcinoma).
  • Advanced cardiopulmonary disease
  • Pregnancy
  • Patients with extrahepatic malignancy

Trial design

450 participants in 2 patient groups

cirrhosis with baseline renal function
Description:
500 patients of cirrhosis with normal baseline renal function will be enrolled.
Cirrhosis with Acute Kidney Injury (AKI).
Description:
Cirrhotics patients who present with AKI (Acute Kidney Injury) will be enrolled.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems